Scientists have discovered a new quality control mechanism in the brain that prevents the buildup of harmful glycogen structures called polyglucosan bodies, which can cause severe diseases. This process involves the E3 ubiquitin ligase RNF213, which tags abnormal glycogen for removal through a process called autophagy. Mice lacking RNF213 activity accumulate polyglucosan in critical brain areas, highlighting its importance. RNF213 specifically targets abnormal glycogen, and its activity is regulated by its CBM20 domain. This discovery reveals a complex network of enzymes that maintain glycogen quality, with RNF213 playing a crucial role. The findings emphasize the significance of non-protein ubiquitylation in cellular health and open new avenues for understanding and potentially treating diseases related to glycogen accumulation.
QUESTION: How might understanding the role of RNF213 in glycogen quality control influence future treatments for diseases caused by polyglucosan accumulation?
